ABEONA THERAPEUTICS INC. — Director's Dealing 2021

Mar 23, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABEONA THERAPEUTICS INC. (ABEO)
CIK: 0000318306
Period of Report: 2021-03-19

Reporting Person: Amoroso Michael (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-19	Common stock	A	250000	—	Acquired	695455	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-19	Stock Option (right to buy)	$2.18	A	500000	Acquired	2031-03-19	Common Stock (500000)	Direct

Footnotes

F1: The restricted stock will vest 25% on each of March 19, 2022 and in 12 quarterly installments thereafter.

F2: The options will vest 25% on March 19, 2022, and in 36 equal monthly installments thereafter.